ZimVie Opens State-of-the-Art Dental Science Educational and Training Institute in Palm Beach Gardens, Florida

April 27, 2023

Modernized 11,000 sq. ft. facility equipped for hands-on dental education and training underscores company’s commitment to lead the industry in advancing professional development of dental practitioners

WESTMINSTER, Colo., April 27, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the opening of its new, state-of-the-art educational facility for dental practitioners in Palm Beach Gardens, Florida. ZimVie Institute South features over 11,000 sq. ft. of dedicated education and training space, offering the latest life-like simulated patient models, a cadaver lab, and a fully integrated digital workflow with 3D printing capabilities, RealGUIDE™ software, and a mill.

“We are thrilled to open ZimVie Institute South, our sixth and most advanced educational facility, and to welcome clinicians from around the world. Life-like instruction and training are core values within our educational platform. Our new and most comprehensive Institute will allow practitioners to experience the benefits of our innovative solutions, technology, and support,” said Indraneel Kanaglekar, SVP and President of ZimVie Dental. “We look forward to expanding and growing our reach with a modern facility to complement our team’s commitment to continued innovation and education.”

ZimVie’s newest facility expands its Institute model to allow the company to host cadaver and simulation courses that teach advanced surgical and restorative techniques for full mouth reconstructions. It also hosts comprehensive training events on everything from practice management to digital workflow training using ZimVie’s RealGUIDE software. Located at ZimVie Dental’s headquarters, the facility is also home to product manufacturing, allowing Institute guests the opportunity to see firsthand where and how ZimVie products are made. The Institute is now active and is projected to host more than 1,500 dental professionals annually, bolstering ZimVie’s broader educational footprint. Globally, ZimVie trains more than 100,000 dental professionals across its six Institutes and virtual programs every year.

A Media Snippet accompanying this announcement is available by clicking on the image or link below:

For more information on ZimVie Dental implants, suite of connected solutions, and continuing education, please visit www.zimvie.com.

About ZimVie
ZimVie is a global life sciences leader in the dental and spine markets that develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to treat a wide range of spine pathologies and support dental tooth replacement and restoration procedures. The company was founded in March 2022 as an independent, publicly traded spin-off of the Dental and Spine business units of Zimmer Biomet to breathe new life, dedicated energy, and strategic focus to its portfolio of trusted brands and products. From its headquarters in Westminster, Colorado, and additional facilities around the globe, the company serves customers in over 70 countries worldwide with a robust offering of dental and spine solutions including differentiated product platforms supported by extensive clinical evidence. For more information about ZimVie, please visit us at www.ZimVie.com. Follow @ZimVie on Twitter, Facebook, LinkedIn, or Instagram.

For Customers
Customers and guests are able to stay at the partnering PGA National Resort, just minutes away from ZimVie Institute South, to provide the best possible experience for visiting dental professionals. ZimVie Institute South is located at 4600 E. Park Drive, Palm Beach Gardens, FL.

Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements concerning ZimVie’s expectations, plans, prospects, and product and service offerings, including new product launches and potential clinical successes. Such statements are based upon the current beliefs, expectations, and assumptions of management and are subject to significant risks, uncertainties, and changes in circumstances that could cause actual outcomes and results to differ materially from the forward-looking statements. For a list and description of some of such risks and uncertainties, see ZimVie’s periodic reports filed with the U.S. Securities and Exchange Commission (SEC). These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in ZimVie’s filings with the SEC. Forward-looking statements speak only as of the date they are made, and ZimVie disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Readers of this press release are cautioned not to rely on these forward-looking statements, since there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary note is applicable to all forward-looking statements contained in this press release.

Media Contact Information:

Laura Driscoll • Laura.Driscoll@ZimVie.com
(774) 284-1606

Allison Johnson • Allison.Johnson@ZimVie.com
(774) 266-8046

Investor Contact Information:

Gilmartin Group LLC
Marissa Bych • Marissa@gilmartinir.com

back to top of the page button